Vir Biotechnology, Inc. SEC filings VIR

Vir Biotechnology, Inc. has 801 filings in SEC EDGAR's recent list, going back to Jun 29, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Vir Biotechnology, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 3, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
4 Insider transaction Oct 28, 2026 Oct 27, 2026
3 Initial insider ownership Oct 28, 2026 Oct 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
3 Initial insider ownership Oct 6, 2026 Oct 5, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 9, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 10, 2026 Jun 9, 2026
3 Initial insider ownership Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 4, 2026 May 1, 2026
4 Insider transaction Apr 30, 2026 Apr 29, 2026
144 Notice of proposed sale Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 7, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 24, 2026 Mar 23, 2026
4 Insider transaction Mar 23, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 23, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 3, 2026 —
4 Insider transaction Mar 3, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
4 Insider transaction Feb 24, 2026 Feb 22, 2026
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
4 Insider transaction Feb 3, 2026 Feb 2, 2026
144 Notice of proposed sale Jan 14, 2026 —
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 18, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 4, 2025 Nov 3, 2025
4 Insider transaction Nov 4, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 28, 2025 Oct 24, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
144 Notice of proposed sale Oct 21, 2025 —
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 14, 2025 Oct 9, 2025
4 Insider transaction Oct 9, 2025 Oct 7, 2025
4 Insider transaction Oct 7, 2025 Oct 3, 2025
144 Notice of proposed sale Oct 3, 2025 —
4 Insider transaction Oct 2, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 3, 2025 Sep 2, 2025
4 Insider transaction Aug 4, 2025 Aug 1, 2025
4 Insider transaction Jul 17, 2025 Jul 15, 2025
144 Notice of proposed sale Jul 17, 2025 —
144 Notice of proposed sale Jul 15, 2025 —
4 Insider transaction Jul 2, 2025 Jul 1, 2025
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jun 11, 2025 —
144 Notice of proposed sale Jun 10, 2025 —
4 Insider transaction Jun 9, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
144 Notice of proposed sale Jun 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
4 Insider transaction Apr 4, 2025 Apr 3, 2025
144 Notice of proposed sale Apr 3, 2025 —
4 Insider transaction Feb 27, 2025 Feb 26, 2025
144 Notice of proposed sale Feb 26, 2025 —
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
4 Insider transaction Feb 19, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 18, 2025 —
4 Insider transaction Feb 14, 2025 Feb 13, 2025
144 Notice of proposed sale Feb 13, 2025 —
4 Insider transaction Jan 8, 2025 Jan 8, 2025
144 Notice of proposed sale Jan 8, 2025 —
4 Insider transaction Dec 4, 2024 Dec 2, 2024
144 Notice of proposed sale Dec 2, 2024 —
4 Insider transaction Nov 18, 2024 Nov 15, 2024
4 Insider transaction Nov 7, 2024 Nov 6, 2024
144 Notice of proposed sale Nov 6, 2024 —
4 Insider transaction Nov 5, 2024 Nov 1, 2024
144 Notice of proposed sale Nov 5, 2024 —
4 Insider transaction Oct 24, 2024 Oct 23, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
3 Initial insider ownership Oct 3, 2024 Oct 2, 2024
3 Initial insider ownership Oct 2, 2024 Oct 1, 2024
3 Initial insider ownership Oct 2, 2024 Oct 1, 2024
4 Insider transaction Sep 10, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Jul 16, 2024 Jul 15, 2024
144 Notice of proposed sale Jul 10, 2024 —
4 Insider transaction Jun 12, 2024 Jun 12, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
144 Notice of proposed sale Jun 11, 2024 —
144 Notice of proposed sale Jun 7, 2024 —
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024
3 Initial insider ownership Jun 3, 2024 Jun 3, 2024
4 Insider transaction May 31, 2024 May 29, 2024
3 Initial insider ownership May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
3 Initial insider ownership May 31, 2024 May 29, 2024
4 Insider transaction Apr 4, 2024 Apr 3, 2024
144 Notice of proposed sale Apr 4, 2024 —
144 Notice of proposed sale Apr 3, 2024 —
4 Insider transaction Apr 2, 2024 Apr 1, 2024
4 Insider transaction Mar 28, 2024 Mar 27, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
144 Notice of proposed sale Feb 26, 2024 —
4 Insider transaction Feb 20, 2024 Feb 16, 2024
144 Notice of proposed sale Feb 20, 2024 —
4 Insider transaction Feb 16, 2024 Feb 16, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Jan 24, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Oct 20, 2023 Oct 19, 2023
4 Insider transaction Oct 18, 2023 Oct 17, 2023
4 Insider transaction Sep 18, 2023 Sep 15, 2023
4 Insider transaction Jul 5, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VIR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1706431

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.